|
NUCRYST Pharmaceuticals appointed a Scientific Advisory Board to provide advice on scientific, clinical and regulatory matters for its nanocrystalline technology products. The Scientific Advisory Board represents a distinguished and accomplished group of individuals with expertise encompassing disciplines appropriate to current and future interests of NUCRYST.
NUCRYST Pharmaceuticals' Scientific Advisory Board Members
Allen J. Bard, PhD - Robert H. Demling, MD - Byron D. McLees, MD, PhD - Robert S. Stern, MD - Michael Weintraub, MD
Allen J. Bard, PhD
-
Hackerman-Welch Regents Chair in Chemistry
-
Department of Chemistry and Biochemistry
-
The University of Texas at Austin
-
Member National Academy of Science
-
Formerly Editor-in-Chief, Journal of the American Chemical Society
-
Formerly President, International Union of Pure and Applied Chemistry
Robert H. Demling, MD
-
Professor of Surgery; Director, Longwood Area Trauma Center, Harvard Medical School, Boston
-
Director, Intensive Care Unit; Director, Burn Center
-
Surgeon, Brigham and Women's Hospital, Boston
-
Past President, American Burn Association
Byron D. McLees, MD, PhD
-
Vice President, Research, Surgical Review Corporation
-
Formerly, Chief Medical Officer, ClinTrials Research, Inc.
-
Formerly, President, MPI Development
-
Formerly, Vice President Worldwide Clinical Development and Medical Affairs, Proctor and Gamble Pharmaceuticals
-
Formerly, Chief Medical Officer, The Upjohn Company
-
Formerly, Professor of Medicine and Director of Pulmonary/Critical Care Medicine, Bowman Gray School of Medicine
Robert S. Stern, MD
-
Professor of Dermatology, Harvard Medical School
-
Chairman, Department of Dermatology, Beth Israel Deaconess Medical Center, Boston
-
Formerly, Chairman, Dermatologic Drugs Advisory Committee, US Food and Drug Administration
Michael Weintraub, MD
-
Formerly, Head, Clinical Pharmacology, University of Rochester Medical School, New York
-
Formerly, Director, Office of Drug Evaluation 5 (OTC Drugs, Dermatologic/Dental Drugs, Analgesics, Anti-inflammatory and Ophthalmologic Drugs), US Food and Drug Administration
|
